Cardiovascular Protection With Antihypertensive Drugs in Dialysis Patients: Systematic Review and Meta-Analysis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  HYPERTENSION

• Publication date

  2009-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.108.128116PMID 19273737PMCID PMC2728674
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration

  2011cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions

  2010cited by this paper
• Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association.

  2008cited by this paper
• Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients

  2008cited by this paper
• Call to Action on Use and Reimbursement for Home Blood Pressure Monitoring: A Joint Scientific Statement From the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association

  2008cited by this paper
• Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial.

  2008cited by this paper
• Improving blood pressure control in hypertensive hemodialysis patients.

  2007cited by this paper
• Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis

  2007cited by this paper
• Home blood pressures are of greater prognostic value than hemodialysis unit recordings.

  2007cited by this paper
• Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization?

  2007cited by this paper
• Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies.

  2006cited by this paper
• Changing relationship of blood pressure with mortality over time among hemodialysis patients.

  2006cited by this paper
• Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis--a randomized study.

  2006cited by this paper
• Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure.

  2006cited by this paper
• The epidemiology of systolic blood pressure and death risk in hemodialysis patients.

  2006cited by this paper
• Mortality risk among hemodialysis patients receiving different vitamin D analogs.

  2006cited by this paper
• Reverse Epidemiology of Hypertension and Cardiovascular Death in the Hemodialysis Population: The 58th Annual Fall Conference and Scientific Sessions

  2005cited by this paper
• Hypertension and survival in chronic hemodialysis patients--past lessons and future opportunities.

  2005cited by this paper
• Exploring the paradoxical relationship of hypertension with mortality in chronic hemodialysis

  2004cited by this paper
• Blood pressure control by home monitoring: meta-analysis of randomised trials

  2004cited by this paper
• PCNA: Preventive Cardiovascular Nurses Association

  2004cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial.

  2003cited by this paper
• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  2002cited by this paper
• Importance of blood pressure control in hemodialysis patient survival.

  2000cited by this paper
• Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients.

  1999cited by this paper
• Bias in location and selection of studies.

  1998cited by this paper
• meta-analysis bias in location and selection of studies

  1998cited by this paper
• "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc.

  1998cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• The Cochrane collaboration.

  1996cited by this paper
• II. Coronary Heart Disease in the Framingham Study

  1957cited by this paper
• Coronary heart disease in the Framingham study.

  1957cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper
• Original Report: Patient-oriented, Translational Research Location Not Quantity of Blood Pressure Measurements Predicts Mortality in Hemodialysis Patients

  year unknowncited by this paper

• Operationalizing Home Blood Pressure Monitoring for Dialysis Patients: An Effectiveness-Implementation Hybrid Study

  2025cites this paper
• Hypertension and Blood Pressure Control in Hemodialysis Patients

  2025cites this paper
• Cardiorenal Syndrome: Molecular Pathways Linking Cardiovascular Dysfunction and Chronic Kidney Disease Progression

  2025cites this paper
• I Brazilian guideline on hypertension in dialysis of the Brazilian Society of Nephrology

  2025cites this paper
• Management of blood pressure in adults, children and young people on dialysis: UK kidney association clinical practice guideline

  2025cites this paper
• Interpretability of Home Blood Pressure Measurements in Haemodialysis A Post Hoc Analysis of a Randomised Cross‐Over Study

  2025cites this paper
• I Diretriz Brasileira de hipertensão arterial na diálise da Sociedade Brasileira de Nefrologia

  2025cites this paper
• Should We Use Renin–Angiotensin-System Inhibitors As a First-Line Therapy for the Management of Hypertension in Patients Receiving Hemodialysis?

  2025cites this paper
• Impact of Angiotensin Receptor Blockers (ARB) versus Other Antihypertensive Medication on Blood Pressure in Patients on Dialysis: A Meta-Analysis

  2024cites this paper
• INTRADIALYTIC COMPLICATIONS IN PATIENTS OF END-STAGE RENAL DISEASE ON MAINTENANCE HEMODIALYSIS

  2024cites this paper
• Serum irisin levels are negatively associated with blood pressure in dialysis patients

  2023cites this paper
• Long term reduction of cardiovascular risk factors associated with three hour daily dialysis: A prospective, cohort study

  2023cites this paper
• Which blood pressure metrics should be used in patients on dialysis?

  2023influential citation
• Pharmacological management of hypertension and outcome among patients on hemodialysis at Muhimbili National Hospital, Tanzania: a cross-sectional study

  2023cites this paper
• Real‐world trends in pre‐dialysis blood pressure levels of patients undergoing dialysis in Japan using a web‐based national database

  2023cites this paper
• Multi-Centered Retrospective Study for the Analysis of Efficacy of Antihypertensive Drugs in End Stage Renal Disease Patients: Pre-dialysis versus Post-Dialysis

  2023cites this paper
• Hypertension in Patients Receiving Dialysis: A Review of the Current Clinical Approach

  2023cites this paper
• Diagnosis and treatment of hypertension in dialysis patients: a systematic review

  2023cites this paper
• Influence of blood pressure variations during hemodialysis on the prognosis of dialysis patients

  2023cites this paper
• Antihypertensive treatment of end-stage renal disease patients on hemodialysis does not alter circulating ACE and ACE2 activity and angiotensin peptides.

  2023cites this paper
• Resistant hypertension in dialysis.

  2023cites this paper
• The Controversies of Coronary Artery Disease in End-Stage Kidney Disease Patients: A Narrative Review

  2023cites this paper
• Sodium First Approach, to Reset Our Mind for Improving Management of Sodium, Water, Volume and Pressure in Hemodialysis Patients, and to Reduce Cardiovascular Burden and Improve Outcomes

  2022cites this paper
• Hypertension management in patients with cardiovascular comorbidities.

  2022cites this paper
• Hypertension in Dialysis Patients: Diagnostic Approaches and Evaluation of Epidemiology

  2022cites this paper
• Clinical characteristics and management of hemodialysis patients with pre-dialysis hypertension: a multicenter observational study

  2022cites this paper
• Effect of angiotensin converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis.

  2022cites this paper
• Difference in Antihypertensive Medication Pattern in the First Year Compared to More than a Year of Maintenance Hemodialysis: A Northern India Tertiary Care Experience

  2022cites this paper
• Management of intradialytic hypertension: current evidence and future perspectives

  2022cites this paper
• Prevention and management of cardiovascular disease in kidney disease and kidney failure

  2022cites this paper
• Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021

  2022cites this paper
• Effect of amlodipine versus bisoprolol in hypertensive patients on maintenance hemodialysis

  2021cites this paper
• Is Ambulatory Blood Pressure Monitoring Required for Elderly Hemodialysis Patients during the Interdialytic Period? - Experience of a Tertiary Care Center in South India

  2021cites this paper
• A machine learning pipeline revealing heterogeneous responses to drug perturbations on vascular smooth muscle cell spheroid morphology and formation

  2021cites this paper
• Therapeutic Options to Improve Cardiovascular Outcomes with Long-Term Hemodialysis.

  2021cites this paper
• Hypertension in end-stage kidney disease

  2021cites this paper
• Occurrence, seasonal variation, mass loading and fate of pharmaceuticals and personal care products (PPCPs) in sewage treatment plants in cities of upper Ganges bank, India

  2021cites this paper
• Risk Factor for Hypertension in Hemodialysis Patients

  2020cites this paper
• Renal Parenchymal Disease

  2020cites this paper
• Evaluation of management and factors associated with hypertension control in hemodialysis patients at a tertiary-care hospital in Pakistan

  2020cites this paper
• Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials.

  2020cites this paper
• The Burden of Coronary Artery Disease in Chronic Kidney Disease

  2020cites this paper
• Hypertension Drug Therapy.

  2020cites this paper
• Pharmacist counseling is an important factor in lowering blood pressure of hemodialysis patients with hypertension

  2020cites this paper
• The Impact of Inflammatory Profile on Selenium Levels in Hemodialysis Patients

  2020cites this paper
• Antihypertensive therapy in patients receiving maintenance hemodialysis: a narrative review of the available clinical-trial evidence.

  2020cites this paper
• Coronary Artery Disease: Therapeutics and Drug Discovery

  2020cites this paper
• Blood pressure targets and pharmacotherapy for hypertensive patients on hemodialysis

  2020cites this paper
• Hypertension in End-Stage Renal Disease

  2020cites this paper
• Uncertainties in BP management in dialysis patients

  2020cites this paper
• Efficacy and safety of intradialytic exercise in haemodialysis patients: a systematic review and meta-analysis

  2019cites this paper
• Apparent Treatment-Resistant Hypertension and Cardiovascular Risk in Hemodialysis Patients: Ten-Year Outcomes of the Q-Cohort Study

  2019cites this paper
• Antihypertensive Agents in the Dialysis Patient

  2019cites this paper
• Atherosclerosis in Chronic Kidney Disease.

  2019cites this paper
• Treatment of Central Nervous System Complications of Renal Dialysis and Transplantation

  2019cites this paper
• Up‐regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide

  2019cites this paper
• New insights on the renal protective effects of mineralocorticoid receptor antagonists.

  2019cites this paper
• Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study.

  2019cites this paper
• Hypertension in patients on dialysis: diagnosis, mechanisms, and management

  2018cites this paper
• Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD.

  2018cites this paper
• Big data in nephrology—a time to rethink

  2018cites this paper
• Blood pressure target for the dialysis patient

  2018cites this paper
• Current and potential therapeutic strategies for the management of vascular calcification in patients with chronic kidney disease including those on dialysis

  2018cites this paper
• Blood pressure control in conventional hemodialysis

  2018cites this paper
• Dialysepatienten

  2018cites this paper
• Establishing the minimal sufficient number of measurements to validate a 24h blood pressure recording

  2018cites this paper
• Beta blockers in patients with end‐stage renal disease—Evidence‐based recommendations

  2018cites this paper
• Hypertension in Dialysis Patients: Clinical Epidemiology, Pathogenesis, Diagnosis, and Treatment

  2018cites this paper
• Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in Chronic Kidney Disease

  2018cites this paper
• Patient-Centered Approach for Hypertension Management in End-Stage Kidney Disease: Art or Science?

  2018cites this paper
• Peridialysis BP levels and risk of all-cause mortality: a dose-response meta-analysis

  2018cites this paper
• Increased Weight Gain During the Long Interdialytic Period Is Associated with Minor Effects on Blood Pressure Control in Clinically Stable In-Centre Haemodialysis Patients

  2018cites this paper
• Eicosapentaenoic Acid as a Potential Therapeutic Approach to Reduce Cardiovascular Risk in Patients with End-Stage Renal Disease on Hemodialysis: A Review

  2017cites this paper
• Blood pressure targets for hemodialysis patients.

  2017cites this paper
• Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial

  2017cites this paper
• The relationship between survival rate and intradialytic blood pressure changes in maintenance hemodialysis patients

  2017cites this paper
• Blood Pressure of Maintenance Hemodialysis Patients in the Dalmatian Region of Croatia: Differences between Hospital and Out-of-Hospital Dialysis Centers

  2017cites this paper
• Blood pressure in hemodialysis: targets?

  2017cites this paper
• Pathogenesis and treatment of hypertension in haemodialysis patients with chronic kidney disease

  2017cites this paper
• Fitting Mixed Effects Models with Big Data

  2017cites this paper
• Cardiovascular Risk Factors: The Old Ones and a Closer Look to the Mineral Metabolism

  2017cites this paper
• The Risk of Cardiovascular Disease Is Not Increasing Over Time Despite Aging and Higher Comorbidity Burden of Kidney Transplant Recipients

  2017cites this paper
• PHARMACOTHERAPY OF ARTERIAL HYPERTENSION AT REPLACEMENT KIDNEY THERAPY

  2017cites this paper
• Hypertension in End-Stage Renal Disease: Dialysis

  2017cites this paper
• Blood Pressure and Risk of Cardiovascular Events in Patients on Chronic Hemodialysis: The CRIC Study (Chronic Renal Insufficiency Cohort)

  2017cites this paper
• Special situations: Intradialytic hypertension/chronic hypertension and intradialytic hypotension

  2017cites this paper
• Chapter 55 – Avoidance and Treatment of Cardiovascular Disease in Dialysis

  2017cites this paper
• Cardiac Pre-operative Evaluation as an Opportunity to Optimize Risk Factors in Kidney Transplant Candidates

  2017cites this paper
• The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study

  2017cites this paper
• Multiphasic effects of blood pressure on survival in hemodialysis patients.

  2016cites this paper
• Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis

  2016cites this paper
• Managing Blood Pressure in the Elderly: What Is Different?

  2016cites this paper
• Blood Pressure and Mortality in Long-Term Hemodialysis—Time to Move Forward

  2016cites this paper
• Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis

  2016cites this paper
• Readmissions related to antihypertensive medications used in chronic hemodialysis

  2016cites this paper
• Hypertension Management in Transition: From CKD to ESRD.

  2016cites this paper
• Management of hypertension for patients undergoing dialysis therapy

  2016cites this paper
• Hypertension in the Hemodialysis Patient.

  2016cites this paper
• New Potassium Binders: A Call to Test Their Efficacy and Safety in Dialysis Patients.

  2016cites this paper
• Hypertension in the Dialysis Patient

  2016cites this paper